Abstract:Network data is composed of nodes and edges. Successful application of machine learning/deep learning algorithms on network data to make node classification and link prediction have been shown in the area of social networks through which highly customized suggestions are offered to social network users. Similarly one can attempt the use of machine learning/deep learning algorithms on biological network data to generate predictions of scientific usefulness. In the presented work, compound-drug target interaction network data set from bindingDB has been used to train deep learning neural network and a multi class classification has been implemented to classify PubChem compound queried by the user into class labels of PBD IDs. This way target interaction prediction for PubChem compounds is carried out using deep learning. The user is required to input the PubChem Compound ID (CID) of the compound the user wishes to gain information about its predicted biological activity and the tool outputs the RCSB PDB IDs of the predicted drug target interaction for the input CID. Further the tool also optimizes the compound of interest of the user toward drug likeness properties through a deep learning based structure optimization with a deep learning based drug likeness optimization protocol. The tool also incorporates a feature to perform automated In Silico modelling for the compounds and the predicted drug targets to uncover their protein-ligand interaction profiles. The program is hosted, supported and maintained at the following GitHub repository https://github.com/bengeof/Compound2DeNovoDrugPropMax Anticipating the rise in the use of quantum computing and quantum machine learning in drug discovery we use the Penny-lane interface to quantum hardware to turn classical Keras layers used in our machine/deep learning models into a quantum layer and introduce quantum layers into classical models to produce a quantum-classical machine/deep learning hybrid model of our tool and the code corresponding to the same is provided below https://github.com/bengeof/QPoweredCompound2DeNovoDrugPropMax

Data-driven reactivity prediction of targeted covalent inhibitors using computed quantum features for drug discovery

A hybrid quantum computing pipeline for real world drug discovery

“Quantum-Chemoinformatics” for Design and Discovery of New Molecules and Reactions

Quantum Machine Learning for Drug Discovery

Chemical Reactivity Prediction: Current Methods and Different Application Areas

Efficient Hamiltonian Simulation: A Utility Scale Perspective for Covalent Inhibitor Reactivity Prediction

Modern Semiempirical Electronic Structure Methods and Machine Learning Potentials for Drug Discovery: Conformers, Tautomers, and Protonation States

Quantum Machine Learning Algorithms for Drug Discovery Applications

A perspective on the current state-of-the-art of quantum computing for drug discovery applications

A Quantum Computing Pipeline for Real World Drug Discovery: From Algorithm to Quantum Hardware

Discrete Fourier Transform Improves the Prediction of the Electronic Properties of Molecules in Quantum Machine Learning

Quantum Computing in Pharma: A Multilayer Embedding Approach for Near Future Applications

Quantum Machine Learning Predicting ADME-Tox Properties in Drug Discovery

Robust Quantum Reservoir Computing for Molecular Property Prediction

QPowered Compound2DeNovoDrugPropMax –A Novel Programmatic Tool Incorporating Deep Learning and In Silico Methods for Automated In Silico Bio- Activity Discovery for any Compound of Interest

Near-Term Quantum Classification Algorithms Applied to Antimalarial Drug Discovery

Insights from incorporating quantum computing into drug design workflows

Quantum mechanical-based strategies in drug discovery: Finding the pace to new challenges in drug design

A hybrid quantum-classical fusion neural network to improve protein-ligand binding affinity predictions for drug discovery

Quantum Molecular Docking with a Quantum-Inspired Algorithm